Medical Care

Global Adeno-Associated Virus Gene Therapy Market Research Report 2025

The global market for Adeno-Associated Virus Gene Therapy was valued at US$ 1721 million in the year 2024 and is projected to reach a revised size of US$ 2836 million by 2031, growing at a CAGR of 7.5% during the forecast period.
North American market for Adeno-Associated Virus Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Adeno-Associated Virus Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Adeno-Associated Virus Gene Therapy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Adeno-Associated Virus Gene Therapy include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed, BiBo Biopharma Engineering Co., Ltd., Beihai Kangcheng, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus Gene Therapy.
The Adeno-Associated Virus Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adeno-Associated Virus Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adeno-Associated Virus Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., Ltd.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Segment by Type
Gene Silencing
Gene Replacement
Gene Addition
Gene Editing
Segment by Application
Hospitals
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adeno-Associated Virus Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Silencing
1.2.3 Gene Replacement
1.2.4 Gene Addition
1.2.5 Gene Editing
1.3 Market by Application
1.3.1 Global Adeno-Associated Virus Gene Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adeno-Associated Virus Gene Therapy Market Perspective (2020-2031)
2.2 Global Adeno-Associated Virus Gene Therapy Growth Trends by Region
2.2.1 Global Adeno-Associated Virus Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Adeno-Associated Virus Gene Therapy Historic Market Size by Region (2020-2025)
2.2.3 Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2026-2031)
2.3 Adeno-Associated Virus Gene Therapy Market Dynamics
2.3.1 Adeno-Associated Virus Gene Therapy Industry Trends
2.3.2 Adeno-Associated Virus Gene Therapy Market Drivers
2.3.3 Adeno-Associated Virus Gene Therapy Market Challenges
2.3.4 Adeno-Associated Virus Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adeno-Associated Virus Gene Therapy Players by Revenue
3.1.1 Global Top Adeno-Associated Virus Gene Therapy Players by Revenue (2020-2025)
3.1.2 Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Adeno-Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Adeno-Associated Virus Gene Therapy Revenue
3.4 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio
3.4.1 Global Adeno-Associated Virus Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus Gene Therapy Revenue in 2024
3.5 Global Key Players of Adeno-Associated Virus Gene Therapy Head office and Area Served
3.6 Global Key Players of Adeno-Associated Virus Gene Therapy, Product and Application
3.7 Global Key Players of Adeno-Associated Virus Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adeno-Associated Virus Gene Therapy Breakdown Data by Type
4.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Type (2020-2025)
4.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2026-2031)
5 Adeno-Associated Virus Gene Therapy Breakdown Data by Application
5.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Application (2020-2025)
5.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Adeno-Associated Virus Gene Therapy Market Size (2020-2031)
6.2 North America Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025)
6.4 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adeno-Associated Virus Gene Therapy Market Size (2020-2031)
7.2 Europe Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025)
7.4 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size (2020-2031)
8.2 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adeno-Associated Virus Gene Therapy Market Size (2020-2031)
9.2 Latin America Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025)
9.4 Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size (2020-2031)
10.2 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Details
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Introduction
11.1.4 Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.1.5 Creative Biolabs Recent Development
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Details
11.2.2 Affinia Therapeutics Business Overview
11.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.2.4 Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.2.5 Affinia Therapeutics Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.3.4 Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.3.5 Spark Therapeutics Recent Development
11.4 AGC Biologics
11.4.1 AGC Biologics Company Details
11.4.2 AGC Biologics Business Overview
11.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Introduction
11.4.4 AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.4.5 AGC Biologics Recent Development
11.5 StrideBio
11.5.1 StrideBio Company Details
11.5.2 StrideBio Business Overview
11.5.3 StrideBio Adeno-Associated Virus Gene Therapy Introduction
11.5.4 StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.5.5 StrideBio Recent Development
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Details
11.6.2 SIRION Biotech Business Overview
11.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Introduction
11.6.4 SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.6.5 SIRION Biotech Recent Development
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Details
11.7.2 Neurophth Biotechnology Business Overview
11.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Introduction
11.7.4 Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.7.5 Neurophth Biotechnology Recent Development
11.8 Belief BioMed
11.8.1 Belief BioMed Company Details
11.8.2 Belief BioMed Business Overview
11.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Introduction
11.8.4 Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.8.5 Belief BioMed Recent Development
11.9 BiBo Biopharma Engineering Co., Ltd.
11.9.1 BiBo Biopharma Engineering Co., Ltd. Company Details
11.9.2 BiBo Biopharma Engineering Co., Ltd. Business Overview
11.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Introduction
11.9.4 BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.9.5 BiBo Biopharma Engineering Co., Ltd. Recent Development
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Details
11.10.2 Beihai Kangcheng Business Overview
11.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Introduction
11.10.4 Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.10.5 Beihai Kangcheng Recent Development
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Details
11.11.2 PackGene Biotech Business Overview
11.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Introduction
11.11.4 PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.11.5 PackGene Biotech Recent Development
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Details
11.12.2 Sarepta Therapeutics Business Overview
11.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.12.4 Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.12.5 Sarepta Therapeutics Recent Development
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Details
11.13.2 Carbon BioSciences Business Overview
11.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Introduction
11.13.4 Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.13.5 Carbon BioSciences Recent Development
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Details
11.14.2 Kelonia Therapeutics Business Overview
11.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Introduction
11.14.4 Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.14.5 Kelonia Therapeutics Recent Development
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Adeno-Associated Virus Gene Therapy Introduction
11.15.4 Roche Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.15.5 Roche Recent Development
11.16 Remedium Bio
11.16.1 Remedium Bio Company Details
11.16.2 Remedium Bio Business Overview
11.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Introduction
11.16.4 Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025)
11.16.5 Remedium Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene Silencing
Table 3. Key Players of Gene Replacement
Table 4. Key Players of Gene Addition
Table 5. Key Players of Gene Editing
Table 6. Global Adeno-Associated Virus Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Adeno-Associated Virus Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Adeno-Associated Virus Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2020-2025)
Table 10. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Adeno-Associated Virus Gene Therapy Market Share by Region (2026-2031)
Table 12. Adeno-Associated Virus Gene Therapy Market Trends
Table 13. Adeno-Associated Virus Gene Therapy Market Drivers
Table 14. Adeno-Associated Virus Gene Therapy Market Challenges
Table 15. Adeno-Associated Virus Gene Therapy Market Restraints
Table 16. Global Adeno-Associated Virus Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Adeno-Associated Virus Gene Therapy Market Share by Players (2020-2025)
Table 18. Global Top Adeno-Associated Virus Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2024)
Table 19. Ranking of Global Top Adeno-Associated Virus Gene Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Adeno-Associated Virus Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Adeno-Associated Virus Gene Therapy, Headquarters and Area Served
Table 22. Global Key Players of Adeno-Associated Virus Gene Therapy, Product and Application
Table 23. Global Key Players of Adeno-Associated Virus Gene Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adeno-Associated Virus Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Adeno-Associated Virus Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. Creative Biolabs Company Details
Table 49. Creative Biolabs Business Overview
Table 50. Creative Biolabs Adeno-Associated Virus Gene Therapy Product
Table 51. Creative Biolabs Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 52. Creative Biolabs Recent Development
Table 53. Affinia Therapeutics Company Details
Table 54. Affinia Therapeutics Business Overview
Table 55. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 56. Affinia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 57. Affinia Therapeutics Recent Development
Table 58. Spark Therapeutics Company Details
Table 59. Spark Therapeutics Business Overview
Table 60. Spark Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 61. Spark Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 62. Spark Therapeutics Recent Development
Table 63. AGC Biologics Company Details
Table 64. AGC Biologics Business Overview
Table 65. AGC Biologics Adeno-Associated Virus Gene Therapy Product
Table 66. AGC Biologics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 67. AGC Biologics Recent Development
Table 68. StrideBio Company Details
Table 69. StrideBio Business Overview
Table 70. StrideBio Adeno-Associated Virus Gene Therapy Product
Table 71. StrideBio Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 72. StrideBio Recent Development
Table 73. SIRION Biotech Company Details
Table 74. SIRION Biotech Business Overview
Table 75. SIRION Biotech Adeno-Associated Virus Gene Therapy Product
Table 76. SIRION Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 77. SIRION Biotech Recent Development
Table 78. Neurophth Biotechnology Company Details
Table 79. Neurophth Biotechnology Business Overview
Table 80. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Product
Table 81. Neurophth Biotechnology Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 82. Neurophth Biotechnology Recent Development
Table 83. Belief BioMed Company Details
Table 84. Belief BioMed Business Overview
Table 85. Belief BioMed Adeno-Associated Virus Gene Therapy Product
Table 86. Belief BioMed Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 87. Belief BioMed Recent Development
Table 88. BiBo Biopharma Engineering Co., Ltd. Company Details
Table 89. BiBo Biopharma Engineering Co., Ltd. Business Overview
Table 90. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Product
Table 91. BiBo Biopharma Engineering Co., Ltd. Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 92. BiBo Biopharma Engineering Co., Ltd. Recent Development
Table 93. Beihai Kangcheng Company Details
Table 94. Beihai Kangcheng Business Overview
Table 95. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Product
Table 96. Beihai Kangcheng Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 97. Beihai Kangcheng Recent Development
Table 98. PackGene Biotech Company Details
Table 99. PackGene Biotech Business Overview
Table 100. PackGene Biotech Adeno-Associated Virus Gene Therapy Product
Table 101. PackGene Biotech Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 102. PackGene Biotech Recent Development
Table 103. Sarepta Therapeutics Company Details
Table 104. Sarepta Therapeutics Business Overview
Table 105. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 106. Sarepta Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 107. Sarepta Therapeutics Recent Development
Table 108. Carbon BioSciences Company Details
Table 109. Carbon BioSciences Business Overview
Table 110. Carbon BioSciences Adeno-Associated Virus Gene Therapy Product
Table 111. Carbon BioSciences Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 112. Carbon BioSciences Recent Development
Table 113. Kelonia Therapeutics Company Details
Table 114. Kelonia Therapeutics Business Overview
Table 115. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Product
Table 116. Kelonia Therapeutics Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 117. Kelonia Therapeutics Recent Development
Table 118. Roche Company Details
Table 119. Roche Business Overview
Table 120. Roche Adeno-Associated Virus Gene Therapy Product
Table 121. Roche Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 122. Roche Recent Development
Table 123. Remedium Bio Company Details
Table 124. Remedium Bio Business Overview
Table 125. Remedium Bio Adeno-Associated Virus Gene Therapy Product
Table 126. Remedium Bio Revenue in Adeno-Associated Virus Gene Therapy Business (2020-2025) & (US$ Million)
Table 127. Remedium Bio Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Adeno-Associated Virus Gene Therapy Picture
Figure 2. Global Adeno-Associated Virus Gene Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adeno-Associated Virus Gene Therapy Market Share by Type: 2024 VS 2031
Figure 4. Gene Silencing Features
Figure 5. Gene Replacement Features
Figure 6. Gene Addition Features
Figure 7. Gene Editing Features
Figure 8. Global Adeno-Associated Virus Gene Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Adeno-Associated Virus Gene Therapy Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Research Institute Case Studies
Figure 12. Others Case Studies
Figure 13. Adeno-Associated Virus Gene Therapy Report Years Considered
Figure 14. Global Adeno-Associated Virus Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Adeno-Associated Virus Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Adeno-Associated Virus Gene Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Adeno-Associated Virus Gene Therapy Market Share by Players in 2024
Figure 18. Global Top Adeno-Associated Virus Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Adeno-Associated Virus Gene Therapy Revenue in 2024
Figure 20. North America Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Adeno-Associated Virus Gene Therapy Market Share by Country (2020-2031)
Figure 22. United States Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Adeno-Associated Virus Gene Therapy Market Share by Country (2020-2031)
Figure 26. Germany Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Share by Region (2020-2031)
Figure 34. China Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Adeno-Associated Virus Gene Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Adeno-Associated Virus Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Creative Biolabs Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 50. Affinia Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 51. Spark Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 52. AGC Biologics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 53. StrideBio Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 54. SIRION Biotech Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 55. Neurophth Biotechnology Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 56. Belief BioMed Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 57. BiBo Biopharma Engineering Co., Ltd. Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 58. Beihai Kangcheng Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 59. PackGene Biotech Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 60. Sarepta Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 61. Carbon BioSciences Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 62. Kelonia Therapeutics Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 63. Roche Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 64. Remedium Bio Revenue Growth Rate in Adeno-Associated Virus Gene Therapy Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies